Basit öğe kaydını göster

dc.contributor.authorVolkan-Salancı, Bilge
dc.contributor.authorÖzgen Kıratlı, Pınar
dc.date.accessioned2019-12-10T11:30:34Z
dc.date.available2019-12-10T11:30:34Z
dc.date.issued2015
dc.identifier.issn2146-1414
dc.identifier.urihttps://doi.org/10.4274/mirt.76476
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563170/
dc.identifier.urihttp://hdl.handle.net/11655/15781
dc.description.abstractBoth benign and malignant diseases of the thyroid are rare in the pediatric and adolescent population, except congenital hypothyroidism. Nuclear medicine plays a major role, both in the diagnosis and therapy of thyroid pathologies. Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge. This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population.
dc.relation.isversionof10.4274/mirt.76476
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleNuclear Medicine In Thyroid Diseases In Pediatric And Adolescent Patients
dc.typeinfo:eu-repo/semantics/article
dc.relation.journalMolecular Imaging and Radionuclide Therapy
dc.contributor.departmentNükleer Tıp
dc.identifier.volume24
dc.identifier.issue2
dc.identifier.startpage47
dc.identifier.endpage59
dc.description.indexPubMed


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster